Regulation 107 Amendment of regulation 116 (obligation in relation to product information)F1I1
United Kingdom
For regulation 116(2), substitute—
“(2)In this regulation “current scientific knowledge” includes the conclusions of the assessment and recommendations made public by means of—
(a)in the case of a medicinal product authorised by a COR(NI) or COR(UK)—
(i)the European medicines web-portal established in accordance with Article 26 of Regulation (EC) No 726/2004, and
(ii)the UK web-portal established in accordance with regulation 203(1);
(b)in the case of a medicinal product authorised by a COR(GB), the UK web-portal established in accordance with regulation 203(1).”.
Annotations
Textual amendments
- F1
Reg. 107 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 81
Commencement
- I1
Reg. 107 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1